Valuation: IRADIMED CORPORATION

Market Cap 1.29B 1.13B 1.04B 966M 1.83B 123B 1.86B 12.47B 4.83B 60.27B 4.85B 4.74B 208B P/E 2026 *
52.9x
P/E 2027 * 46.6x
Enterprise Value 1.29B 1.13B 1.04B 966M 1.83B 123B 1.86B 12.47B 4.83B 60.27B 4.85B 4.74B 208B EV / Sales 2026 *
14.2x
EV / Sales 2027 * 12.8x
Free-Float
64.8%
Yield 2026 *
-
Yield 2027 * -
1 day+2.99%
1 week+7.56%
Current month+5.66%
1 month+12.36%
3 months+4.93%
6 months+5.73%
Current year+3.79%
1 week 92.68
Extreme 92.68
101.13
1 month 89.69
Extreme 89.69
101.13
Current year 76.95
Extreme 76.95
107.9
1 year 55.11
Extreme 55.1093
107.9
3 years 36.12
Extreme 36.12
107.9
5 years 26
Extreme 26
107.9
10 years 7.85
Extreme 7.85
107.9
Manager TitleAgeSince
Chief Executive Officer 72 2020-05-27
Director of Finance/CFO 64 2022-06-19
Chief Tech/Sci/R&D Officer - 2019-12-31
Director TitleAgeSince
Director/Board Member 73 2013-12-31
Director/Board Member 61 2025-09-01
Director/Board Member 70 2018-12-31
Date Insider Type Main position Quantity % Market Cap.
06-19Fiscal year

Chief Financial Officer

13,911 0.1088%
06-03Sell

Director

-3,000 0.0235%
05-31Sell

Chief Executive Officer

-2,500 0.0196%
Change 5-day change 1-year change 3-year change Capi.($)
+2.99%+7.56%+64.07%+111.50% 1.25B
0.00%+2.34%-17.65%-24.73% 12.54B
-3.09%+6.06%+93.77%+16.59% 5.39B
+0.16%+2.83%-35.64%-64.68% 1.22B
+2.26%+3.04%-36.76%-47.96% 1.1B
-0.14%-0.07%-42.21% - 904M
-0.85%+4.17%+167.76%+163.70% 654M
-1.22%+4.15%+108.00% - 368M
-4.59%+5.34%-54.57%+225.67% 279M
-0.95%-1.89%-25.38%-44.16% 140M
Average -0.54%+6.50%+22.14%+41.99% 2.38B
Weighted average by Cap. -0.54%+7.56%+15.66%-2.14%

Financials

2026 *2027 *
Net sales 91.2M 79.69M 73.18M 68.24M 129M 8.68B 132M 881M 341M 4.26B 342M 335M 14.67B 101M 88.17M 80.96M 75.5M 143M 9.61B 146M 975M 378M 4.71B 379M 371M 16.23B
Net income 24.55M 21.45M 19.7M 18.37M 34.83M 2.34B 35.41M 237M 91.92M 1.15B 92.18M 90.18M 3.95B 27.8M 24.29M 22.31M 20.8M 39.44M 2.65B 40.1M 269M 104M 1.3B 104M 102M 4.47B
Net Debt - -
Logo IRADIMED CORPORATION
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories, disposables and services. Its MRidium 3870 MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium 3860+ MRI Compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to safely and predictably and other IV fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably on magnetic fields of over 30,000 gauss.
Employees
166
Date Price Change Volume
26-07-02 US$100.97 +2.99% 130,062
26-07-01 US$98.04 +2.60% 154,909
26-06-30 US$95.56 +1.58% 109,602
26-06-29 US$94.07 +0.12% 104,749
26-06-26 US$93.96 +0.10% 322,740
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
101.13USD
Average target price
118.00USD
Spread / Average Target
+16.68%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRMD Stock